# Repurposing Chlorpromazine in the Treatment of Glioblastoma

> **NCT04224441** · PHASE2 · UNKNOWN · sponsor: **Marco G Paggi, MD, PhD** · enrollment: 41 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- MGMT-Unmethylated Glioblastoma

## Interventions

- **DRUG:** Chlorpromazine Pill

## Key facts

- **NCT ID:** NCT04224441
- **Lead sponsor:** Marco G Paggi, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-15
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2020-01-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224441, "Repurposing Chlorpromazine in the Treatment of Glioblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04224441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*